News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
875,499 Results
Type
Article (88321)
Company Profile (812)
Press Release (786336)
Multimedia
Podcasts (215)
Webinars (34)
Section
Business (233396)
Career Advice (4153)
Deals (39906)
Drug Delivery (161)
Drug Development (91524)
Employer Resources (206)
FDA (18469)
Job Trends (17451)
News (398263)
Policy (40003)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3033)
Academic (2)
Accelerated approval (43)
Adcomms (37)
Allergies (171)
Alliances (56985)
ALS (205)
Alzheimer's disease (1874)
Antibody-drug conjugate (ADC) (407)
Approvals (18686)
Artificial intelligence (726)
Autoimmune disease (241)
Automation (52)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (216)
Biotechnology (486)
Bladder cancer (185)
Brain cancer (72)
Breast cancer (723)
Cancer (5586)
Cardiovascular disease (493)
Career advice (3582)
Career pathing (45)
CAR-T (324)
CDC (70)
Celiac Disease (2)
Cell therapy (904)
Cervical cancer (42)
Clinical research (77738)
Collaboration (2053)
Company closure (6)
Compensation (1288)
Complete response letters (91)
COVID-19 (3011)
CRISPR (110)
C-suite (1029)
Cystic fibrosis (157)
Data (7103)
Decentralized trials (3)
Denatured (80)
Depression (174)
Diabetes (587)
Diagnostics (7396)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (356)
Drug pricing (234)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (101140)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136322)
Executive appointments (1101)
FDA (21975)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1717)
Gene editing (238)
Generative AI (77)
Gene therapy (750)
GLP-1 (1195)
Government (5499)
Grass and pollen (8)
Guidances (398)
Healthcare (20999)
HIV (80)
Huntington's disease (57)
IgA nephropathy (93)
Immunology and inflammation (319)
Immuno-oncology (89)
Indications (154)
Infectious disease (3354)
Inflammatory bowel disease (222)
Inflation Reduction Act (17)
Influenza (137)
Intellectual property (278)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5204)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (104)
Layoffs (666)
Leadership (45)
Legal (10169)
Liver cancer (102)
Longevity (30)
Lung cancer (746)
Lymphoma (413)
Machine learning (55)
Management (66)
Manufacturing (992)
MASH (192)
Medical device (15131)
Medtech (15213)
Mergers & acquisitions (23091)
Metabolic disorders (1575)
mRNA (212)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (429)
Neuropsychiatric disorders (114)
Neuroscience (3381)
Neurotech (2)
NextGen: Class of 2026 (7712)
Non-profit (5130)
Now hiring (74)
Obesity (770)
Opinion (354)
Ovarian cancer (184)
Pain (243)
Pancreatic cancer (262)
Parkinson's disease (361)
Partnered (39)
Patents (571)
Patient recruitment (599)
Peanut (65)
People (67332)
Pharmaceutical (139)
Pharmacy benefit managers (35)
Phase 1 (24021)
Phase 2 (33744)
Phase 3 (25402)
Pipeline (6932)
Policy (369)
Postmarket research (3554)
Preclinical (10783)
Press Release (72)
Prostate cancer (287)
Psychedelics (61)
Radiopharmaceuticals (326)
Rare diseases (1093)
Real estate (7445)
Recruiting (81)
Regulatory (29557)
Reports (72)
Research institute (2753)
Resumes & cover letters (653)
Rett syndrome (33)
RNA editing (22)
RSV (95)
Schizophrenia (171)
Series A (291)
Series B (210)
Service/supplier (30)
Sickle cell disease (113)
Special edition (29)
Spinal muscular atrophy (182)
Sponsored (51)
Startups (4347)
State (2)
Stomach cancer (21)
Supply chain (127)
Tariffs (101)
The Weekly (132)
Vaccines (1215)
Venture capital (111)
Weight loss (522)
Women's health (115)
Worklife (23)
Date
Today (58)
Last 7 days (560)
Last 30 days (3118)
Last 365 days (32843)
2026 (7827)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (97)
Alaska (7)
Arizona (367)
Arkansas (15)
Asia (51824)
Australia (9104)
California (12629)
Canada (3576)
China (1304)
Colorado (539)
Connecticut (551)
Delaware (380)
Europe (119301)
Florida (1881)
Georgia (410)
Hawaii (4)
Idaho (68)
Illinois (1068)
India (85)
Indiana (589)
Iowa (24)
Japan (495)
Kansas (137)
Kentucky (49)
Louisiana (41)
Maine (85)
Maryland (1566)
Massachusetts (9246)
Michigan (388)
Minnesota (715)
Mississippi (7)
Missouri (152)
Montana (37)
Nebraska (30)
Nevada (139)
New Hampshire (90)
New Jersey (3392)
New Mexico (33)
New York (3325)
North Carolina (1722)
North Dakota (10)
Northern California (6140)
Ohio (389)
Oklahoma (24)
Oregon (54)
Pennsylvania (2522)
Puerto Rico (26)
Rhode Island (53)
South America (1668)
South Carolina (75)
South Dakota (1)
Southern California (4911)
Tennessee (202)
Texas (2012)
United States (45415)
Utah (380)
Vermont (1)
Virginia (323)
Washington D.C. (88)
Washington State (1045)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
There are 875,499 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Wave Stock Cut in Half on Underwhelming Higher Dose Obesity Data
While participants on a lower dose of Wave Life Sciences’ RNA therapy lost 5.3% total fat at the six-month mark, those receiving the higher dose saw a less than 1% drop at three months.
March 26, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Takeda Restructuring Will Affect Workforce, Could Include Layoffs
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 26, 2026
·
40 min read
·
BioSpace Editorial Staff
Rare diseases
Beam’s Base Editor Advances to Pivotal Development on Back of ‘Impressive’ AATD Data
Beam is now in the strongest position of all companies advancing a genetic therapy for alpha-1 antitrypsin deficiency, according to analysts at William Blair.
March 26, 2026
·
1 min read
·
Tristan Manalac
Approvals
Denali Delivers ‘Welcome Positive’ for Rare Disease Space With FDA’s Hunter Syndrome Nod
Avlayah is the first Hunter syndrome therapy approved to address the condition’s neurologic complications, according to Tracy Beth Høeg, acting director of the Center for Drug Evaluation and Research.
March 26, 2026
·
3 min read
·
Tristan Manalac
Pipeline
Sarepta Pushes Past Gene Therapy Debacle as RNA Therapies Show Early Promise
Biomarker data for Sarepta Therapeutics’ RNA programs, licensed from Arrowhead Pharmaceuticals, are “competitive” and “strong,” according to analysts at Jefferies, which projected over $1 billion in peak sales.
March 26, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities
March 26, 2026
·
4 min read
Press Releases
Vicore Publishes the Annual Report for 2025
March 26, 2026
·
1 min read
Press Releases
FoRx Therapeutics Presents Preclinical Data at ACS Spring 2026, Confirming FORX-428’s Potential for Best-in-Class PARG Inhibition
March 26, 2026
·
3 min read
Press Releases
GC Biopharma Receives Marketing Authorization for Varicella Vaccine ‘BARYCELA Inj.’ in Guatemala
March 26, 2026
·
3 min read
Press Releases
BioPorto announces the Annual Report for 2025
March 26, 2026
·
6 min read
1 of 87,550
Next
